SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-14-000044
Filing Date
2014-01-15
Accepted
2014-01-15 20:58:25
Documents
1
Period of Report
2014-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_138983749397865.html 4  
1 FORM 4 wf-form4_138983749397865.xml 4 12054
  Complete submission text file 0001126234-14-000044.txt   13428
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AIMES IA 50010
Business Address
Vahanian Nicholas N. (Reporting) CIK: 0001512114 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 14530821